No Data
No Data
No Data
No Data
No Data
Alvotech's Simponi Biosimilar Candidate Shows Efficacy in Confirmatory Study
Alvotech (ALVO.IC) on Wednesday said the confirmatory clinical trial for its Simponi and Simponi Aria biosimilar candidate AVT05 showed positive results in treating patients with moderate to severe rh
MT NewswiresApr 24 08:07 ET
Express News | Alvotech Announced Positive Topline Results From A Confirmatory Clinical Study For AVT05, Alvotech's Proposed Biosimilar To Simponi And Simponi Aria (Golimumab)
Moomoo 24/7Apr 24 04:02 ET
Express News | Alvotech SA - Confirmatory Clinical Safety and Efficacy Study for Avt05 Met Its Primary Endpoint in Patients With Moderate to Severe Rheumatoid Arthritis
Moomoo 24/7Apr 24 04:00 ET
Express News | Alvotech - Confirmatory Clinical Safety and Efficacy Study for Avt05, Met Its Primary Endpoint
Moomoo 24/7Apr 24 04:00 ET
Express News | Alvotech Announces Topline Results From a Confirmatory Clinical Study for Avt05, a Proposed Biosimilar for Simponi® (Golimumab)
Moomoo 24/7Apr 24 04:00 ET
Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)
TipRanksApr 23 06:07 ET
No Data
No Data